ArticleInfectious diseases and therapy2017

Effect of Hepatitis C Treatment with Ombitasvir/Paritaprevir/R + Dasabuvir on Renal, Cardiovascular and Metabolic Extrahepatic Manifestations: A Post-Hoc Analysis of Phase 3 Clinical Trials.

Darshan A Mehta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.